News Releases

News and information from The Leukemia & Lymphoma Society

Bart Sichel, CMO of Burlington Stores, Elected to LLS Board of Directors

For Immediate Release Contact: Andrea Greif
Tel: (914) 821-8958
Cell: (914) 772-3027
Andrea.greif@lls.org White Plains, N.Y. (April 29, 2015) - Bart Sichel, executive vice president and chief marketing officer at Burlington Stores, has been elected to the national board of directors of The Leukemia & Lymphoma Society (LLS). His term will be effective July 1, 2015 and will conclude ...

Timex Joins The Race Against Time to Accelerate Cancer Cures Through Partnership with LLS

MIDDLEBURY, CT, April 20, 2015 - Timex®, the world's leading global watch manufacturer, is proud to announce today its partnership with The Leukemia & Lymphoma Society as a National Sponsor of The Leukemia Cup Regatta. The Leukemia Cup Regatta is a thrilling series of 45 sailing events in North America that combine the joy of boating with the important task of raising money to cure cancers. Throughout 2015, T...

"Nashville" Star Charles Esten Brings Light to the Dark World of Cancer

Contact: Marcie Klein
Marcie.Klein@lls.org
(914) 821-8205 White Plains, NY, April 13, 2015 - Every three minutes someone in the U.S. is diagnosed with a blood cancer. No one knows this better than "Nashville" star Charles Esten and his wife Patty. Esten's 15-year-old daughter, Addie, was diagnosed with leukemia at age 2 ½. Naturally, their world was turned upside down. But, they quickly le...

PhRMA and LLS Report More Than 240 Medicines in Development to Treat Leukemia, Lymphoma and Other Blood Cancers

FOR IMMEDIATE RELEASE
Contact: Tina Stow
tstow@phrma.org
(202) 835-3581 Washington, D.C. (April 10, 2015) - America's biopharmaceutical research companies are currently developing more than 240 medicines for leukemia, lymphoma, myeloma and other forms of blood cancer, including more targeted treatment options for patients. These collaborative efforts to move research forward are detailed in a ...

Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company

For Immediate Release
Contact: Andrea Greif
Senior Director of Communications
(914)821-8958 (p)
914)772-3027 (c)
andrea.greif@lls.org White Plains, NY - March 30, 2015 - A promising University of Michigan research project focused on developing new treatments for patients with a rare and lethal subtype of leukemia has received a significant boost from a recent licensing agreement ...

Extraordinary Individuals Are Saving Lives Not Someday, But Today

Contact: Kristin Hoose
(914) 821-8973
kristin.hoose@lls.org
White Plains, NY (March 16, 2015) - For 10 weeks, in more than 80 cities across the country, 900 dedicated fundraising participants are competing on a local and national level to help the more than one million Americans who are living with or in remission from a blood cancer. Today, The Leukemia & Lymphoma Society (LLS) is celebr...

Study Commissioned by The Leukemia & Lymphoma Society Shows Benefits of Limiting Out-of-Pocket Costs for Patients Purchasing Prescription Drugs

For Immediate Release
Contact: Andrea Greif
Senior Director of Communications
(914)821-8958 (p)
914)772-3027 (c)
andrea.greif@lls.org
(White Plains, NY) - March 9, 2015 - A new study finds that capping the cost-sharing for prescription drugs on individual policies in the health insurance marketplace would reduce patients' annual out-of-pocket healthcare spending, and have...

The Leukemia & Lymphoma Society Applauds Therapy Advances for Myeloma Patients

For Immediate Release
Contact: Andrea Greif
Senior Director of Communications
(914)821-8958 (p)
914)772-3027 (c)
andrea.greif@lls.org (White Plains, NY) - February 26, 2015  - Two recent approvals by the U.S. Food and Drug Administration (FDA) will provide significant additional options for myeloma patients, both newly diagnosed and previously treated. Myeloma is a relati...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: